SIX · ROP.SW
Roche Holding AG
CHF 403.40+CHF 1.70 (+0.42%)
Roche Holding AG’s quoted price sits in the upper half of its reported 52-week range, 0.62% below the high.
Loading market information…
OTC · BIIO · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bionovate Technologies Corp’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely target and treat these blemishes on any area of the body. The firm plans to distribute these advanced systems globally, marketing them to healthcare providers and wellness centers. Founded in Cham, Switzerland, in 2010, the organization previously traded under the name MJP International Ltd. before adopting Bionovate Technologies Corp. in December 2017. Since October 7, 2020, the company has operated as an affiliated entity of Human Data AG.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:32 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CHF 403.40+CHF 1.70 (+0.42%)
Roche Holding AG’s quoted price sits in the upper half of its reported 52-week range, 0.62% below the high.
CHF 133.78+CHF 1.48 (+1.12%)
Novartis AG’s quoted price sits in the upper half of its reported 52-week range, 0.95% below the high.
$96.60-$0.51 (-0.53%)
Medtronic Plc’s quoted price sits in the upper half of its reported 52-week range, 9.14% below the high.
$0.05+$0.01 (+33.06%)
Oncology Pharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.84% below the high.
$1.34-$0.12 (-8.22%)
Phaos Technology Holdings (Caym’s quoted price sits in the lower half of its reported 52-week range, 98.79% below the high.
$0.01+$0.00 (+14.29%)
Odyssey Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$5.53-$0.26 (-4.41%)
Nuwellis, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.64% below the high.
$0.00$0.00 (0.0%)
BioLife Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
